理气化瘀止泻汤治疗腹泻型肠易激综合征（肝郁乘脾夹瘀证）的临床观察

发布时间：2017-12-28 19:11

本文关键词：理气化瘀止泻汤治疗腹泻型肠易激综合征（肝郁乘脾夹瘀证）的临床观察　出处：《黑龙江中医药大学》2016年硕士论文　论文类型：学位论文

【摘要】：目的：本研究通过对比理气化瘀止泻汤治疗腹泻型肠易激综合征(肝郁乘脾夹瘀证)前后的临床症状、中医证候等的变化,观察理气化瘀止泻汤治疗腹泻型肠易激综合征(肝郁乘脾夹瘀证)的临床疗效。方法：选择符合纳入标准的腹泻型肠易激综合征(肝郁乘脾夹瘀证)患者60例。采用理气化瘀止泻汤治疗。以4周为一个疗程。比较治疗前后中医证候积分,综合评定出理气化瘀止泻汤的临床疗效。采用SPSS19.0统计软件对相关数据进行处理,得出结论。结果：临床疗效总有效率为92.9%,中医证候积分治疗后较治疗前均降低,且有统计学意义(P0.05)。结论：理气化瘀止泻汤能够有效改善或消除腹泻型肠易激综合征(肝郁乘脾夹瘀证)的临床症状,是治疗腹泻型肠易激综合征(肝郁乘脾夹瘀证)有效方剂。
[Abstract]:Objective: This study by comparing Qi stasis Zhixie Decoction in treating diarrhea type of irritable bowel syndrome (liver depression and spleen blood stasis syndrome) before and after the change of clinical symptoms, TCM syndrome, observation of Qi stasis Zhixie Decoction in the treatment of diarrhea predominant irritable bowel syndrome (liver depression and spleen blood stasis syndrome) clinical curative effect. Methods: 60 cases of diarrhea type irritable bowel syndrome (liver depression and splenic clamp stasis syndrome) were selected. It is treated with Qi Qi Huayu Zhixie decoction. 4 weeks as a course of treatment. The TCM syndrome scores were compared before and after the treatment, and the clinical efficacy of Li Qi stasis Zhixie decoction was evaluated. SPSS19.0 statistical software is used to deal with the related data and draw a conclusion. Results: the total effective rate of the clinical curative effect was 92.9%, and the TCM syndrome integral treatment was lower than that before the treatment, and had statistical significance (P0.05). Conclusion: Liqi Huayu Zhixie decoction can effectively improve or eliminate the clinical symptoms of diarrhea predominant irritable bowel syndrome (stagnation of liver qi, spleen and blood stasis). It is an effective prescription for the treatment of diarrhea predominant irritable bowel syndrome (stagnation of liver qi, spleen and blood stasis syndrome).
【学位授予单位】：黑龙江中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R259

【相似文献】